Oppenheimer & Co. Inc. Mourns the Loss of Michael Metz, Chief Investment Strategist

  1. Thursday, August 7, 2008 18:00 EST
  2. Banks, General Financial

NEW YORK, Aug. 7 /PRNewswire-FirstCall/ -- Oppenheimer Holdings Inc. (NYSE and TSX: OPY), today issued the following statement:

"It is with deep sadness that I report the passing last night of Michael Metz, our Chief Investment Strategist," said Albert G. Lowenthal, Chairman and CEO of Oppenheimer Holdings Inc. "He was a kind-hearted and generous man, whose intuitions about the stock market, sense of investment strategy and understanding of client needs were well-honed after years of experience. His wisdom and warmth will be greatly missed."

Mr. Metz began his career as an analyst with Standard & Poor's in 1959. He started at Oppenheimer in 1969 as an analyst, and soon moved to the equity-trading desk where he supported the firm's block trading activities.

From 1990 until 2002, he served as Chief Investment Strategist for Oppenheimer & Co. Inc. In that position, he advised retail and institutional investors and brokers on investment strategy and portfolio selection. He also actively managed investment partnerships for some of the firm's high net-worth clients. He was a Managing Director and the investment decision maker on several investment partnerships for affluent clients in the U.S. and abroad.

Mr. Metz received a B.A. from Dartmouth College, an L.L.B. from Harvard Law School and an L.L.M. from New York University Law School, and served in the United States Navy as a trial lawyer.

A.G. Lowenthal, (212) 668-8000; E.K. Roberts, (416) 322-1515

Copyright 2008 PR Newswire. All Rights Reserved

  1. Print

Related News

  1. Leading Mortgage & Finance Experts Provide Innovative Solution to Housing Crisis
    USAffordable Home, LLC — 22 hours ago
  2. Fannie Mae Redemption
    Fannie Mae — 22 hours ago
  3. Freddie Mac Receives NYSE Notification on Continued Listing
    Freddie Mac — 23 hours ago
  4. MFA Mortgage Investments, Inc. Announces Fourth Quarter 2008 Preferred Dividend of $0.53125
    MFA Mortgage Investment... — 23 hours ago
  5. Keryx Biopharmaceuticals Receives Nasdaq Notification
    Keryx Biopharmaceutical... — 23 hours ago

Subscribe to News Feed

Breaking Stock Market News & Blogs

Market Summary & Related Stocks

DOW NASDAQ S&P 500
7715.56
+163.27
1337.32
+21.20
767.80
+15.36
Ticker Last Trade Change
OPY $8.00 -0.08
Fri Nov 21 Markets Closed » Open in 0h0min